RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,152 | -3.9% | 23,289 | +14.8% | 0.00% | 0.0% |
| Q2 2023 | $26,173 | -4.7% | 20,289 | -2.4% | 0.00% | -50.0% |
| Q1 2023 | $27,452 | -19.7% | 20,797 | -8.8% | 0.00% | 0.0% |
| Q4 2022 | $34,200 | +80.0% | 22,800 | +39.9% | 0.00% | +100.0% |
| Q3 2022 | $19,000 | -20.8% | 16,300 | -23.5% | 0.00% | -50.0% |
| Q2 2022 | $24,000 | -62.5% | 21,300 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $64,000 | +14.3% | 21,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $56,000 | -30.9% | 21,300 | -34.1% | 0.00% | -33.3% |
| Q3 2021 | $81,000 | -15.6% | 32,300 | -26.3% | 0.01% | -14.3% |
| Q2 2021 | $96,000 | +62.7% | 43,800 | +153.2% | 0.01% | +40.0% |
| Q1 2021 | $59,000 | -16.9% | 17,300 | -14.8% | 0.01% | -28.6% |
| Q4 2020 | $71,000 | +36.5% | 20,300 | -7.2% | 0.01% | +16.7% |
| Q3 2020 | $52,000 | – | 21,870 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |